Virtual Screening Approaches Towards the Discovery of Toll-like Receptor 7 (TLR7) Antagonists for the Management of Rheumatoid Arthritis During COVID Infection
Thus, the compounds discovered through the use of various software can possibly be used for the management of rheumatoid arthritis during and after COVID infection. Hence, we can conclude that these molecules might be served as the inhibitors of TLR7 upregulation.
Authors
- Thangavelu Saravanan (ORCID: https://orcid.org/0000-0002-0792-9811)
- Thangavelu Prabha (ORCID: https://orcid.org/0000-0001-6511-0428)
- Dakshinesh Parameswaran
- Jubie Selvaraj (ORCID: https://orcid.org/0000-0002-4633-6621)
- Hemalatha Selvaraj (ORCID: https://orcid.org/0000-0001-6698-8179)
- MVNL Chaitanya (ORCID: https://orcid.org/0000-0001-9432-2374)
- M.K. Kathiravan
- S. Bhuvaneswari
Institutions
- Lovely Professional University (IN)
- JSS Academy of Higher Education and Research (IN)
- SRM Institute of Science and Technology (IN)
- Tamil Nadu Dr. M.G.R. Medical University (IN)
- Government Medical College and Hospital (IN)
- Karpagam Academy of Higher Education (IN)
Publication Details
- Journal
- Current Rheumatology Reviews
- Published
- 2025-04-09
- DOI
- https://doi.org/10.2174/0115733971351438250220063238
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00